ProQR Therapeutics (PRQR)
(Delayed Data from NSDQ)
$2.14 USD
+0.02 (0.94%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $2.16 +0.02 (0.93%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Price, Consensus and EPS Surprise
PRQR 2.14 +0.02(0.94%)
Will PRQR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PRQR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PRQR
Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates
Regenxbio (RGNX) Soars 6.4%: Is Further Upside Left in the Stock?
PRQR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Misses Revenue Estimates
GSK (GSK) Q1 Earnings and Revenues Surpass Estimates
Cara Therapeutics (CARA) Reports Q4 Loss, Tops Revenue Estimates
Other News for PRQR
PRQR Stock Earnings: ProQR Therapeutics Beats EPS, Misses Revenue for Q2 2024
ProQR: Q2 Earnings Snapshot
Wall Street Analysts Are Bullish on Top Healthcare Picks
Optimistic Outlook for ProQR: Solid Financials and Promising Drug Pipeline Justify Buy Rating
ProQR GAAP EPS of -€0.03, revenue of €6.31M